AI-generated summary
The authors report revised Japanese clinical guidelines for male-pattern and female-pattern hair loss, updating a 2010 edition to reflect newer drugs and treatments. They recommend finasteride, dutasteride and topical minoxidil as first-line options for male-pattern hair loss and topical 1% minoxidil for female-pattern hair loss. The abstract describes these as guideline recommendations rather than new trial results, and it does not report the strength of supporting evidence.
- Who or what was studied
- Physicians and patients in Japan; people with male-pattern or female-pattern hair loss
- Limits stated in the abstract
- The abstract is a summary of guideline recommendations and does not report the underlying evidence, study counts or certainty levels.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Androgenetic alopecia. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.